Ryvu Therapeutics S.A.

Prospectus ID: DSP-DSPZE.410.49.2022

Document type
Standalone prospectus
Home member state
Poland
Prospectus type
Standalone Prospectus
Structure
Single document prospectus
Approval / filing date
7 Dec 2022
National document ID
DSP-DSPZE.410.49.2022
Issuer LEI
2594003WO9Q9HHAFL031
Language(s)
Polish

ISINs

  • PLSELVT00013

Passporting

No passporting notifications filed.

Comment

EU Recovery prospectus

Last verified: 2 Nov 2026

Data sourced from the ESMA prospectus register, updated weekly.

Regulatory Q&As

Browse Prospectus Regulation Q&As → Official ESMA interpretations

📋 Track EU financial regulation continuously

Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.

Start free trial → Learn more

14-day free trial. No credit card required.